Naptumomab是一種融合蛋白,由單克隆抗體的抗原結合片段(Fab)與超抗原葡萄球菌腸毒素A(SEA/E-120,“依他芬那妥”)組成。Fab與各種腫瘤細胞表達的抗原5 T4結合,超抗原通過活化T淋巴細胞誘導免疫應答。 Naptumomab生物仿制藥-研究級該產品同種型對照:Bulk Human IgG1 Isotype Control (IB1) [ICH2254] 緩沖液:ICH3002 濃度:5mg/ml 純度:>95% by SDS-PAGE 內毒素:≤ 1.0 EU/mg as determined by the LAL method 制劑:Sterile, preservative-free, solution in PBS. BSA and Azide free.